← The Wire
VNDANasdaq
Vanda Pharmaceuticals Inc.
Pharmaceutical Preparations · DE · CIK 1347178
Develops and commercializes innovative therapies for unmet medical needs using genetics and genomics
red 8-K · 90d
$353M
Market cap
$6.14
Last close
+2.2%
1D
+2.3%
5D
874K
Volume
Price · last 39 sessions-18.8%
May 4L $5.73 · H $7.56Jun 29
408
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 7, 202610-Q10-QOct 30, 202510-Q10-QJul 31, 202510-Q10-QMay 8, 202510-Q10-QNov 7, 202410-Q10-QAug 1, 202410-Q10-QMay 9, 202410-Q10-QNov 9, 202310-Q10-QJul 28, 202310-Q10-QMay 3, 202310-Q10-QNov 3, 202210-Q10-QAug 4, 202210-Q10-QMay 6, 202210-Q10-QNov 4, 202110-Q10-QJul 29, 202110-Q10-QMay 6, 202110-Q10-QOct 29, 202010-Q10-QAug 6, 202010-Q10-QMay 7, 202010-Q10-QNov 7, 201910-Q10-QAug 1, 201910-Q10-QMay 3, 201910-Q10-QNov 7, 201810-Q10-QAug 2, 201810-Q10-QMay 2, 201810-QFORM 10-QNov 8, 201710-Q10-QAug 3, 201710-Q10-QMay 3, 201710-Q10-QNov 3, 201610-QFORM 10-QJul 28, 201610-QFORM 10-QMay 5, 201610-QFORM 10-QNov 4, 201510-QFORM 10-QJul 31, 201510-Q10-QMay 7, 201510-Q10-QOct 27, 201410-QFORM 10-QAug 8, 201410-QFORM 10-QMay 8, 201410-QFORM 10-QNov 8, 201310-QFORM 10-QJul 31, 201310-QFORM 10-QMay 10, 201310-QFORM 10-QNov 8, 201210-QFORM 10-QAug 3, 201210-QFORM 10-QMay 9, 201210-QFORM 10-QNov 7, 201110-QFORM 10-QAug 5, 201110-QFORM 10-QMay 9, 201110-QFORM 10-QNov 8, 201010-Q10-QAug 6, 201010-Q10-QMay 10, 201010-QFORM 10-QNov 4, 200910-QFORM 10-QAug 10, 2009
Insider Activity
In the 90 days to Mar 2, 2026: 6 sold $2.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Polymeropoulos Mihael HristosPresident and CEO | Sell | 156,235 | $8.17 | $1.3M |
| Mar 2, 2026 | Moran Kevin PatrickSVP, CFO & Treasurer | Sell | 42,442 | $8.27 | $351K |
| Mar 2, 2026 | Williams TimothySVP & General Counsel | Sell | 42,434 | $8.27 | $351K |
| Mar 2, 2026 | Birznieks GuntherSVP, Business Development | Sell | 42,431 | $8.27 | $351K |
| Mar 2, 2026 | Wijkstrom JoakimSVP, Chief Marketing Officer | Sell | 30,800 | $8.27 | $255K |
| Feb 23, 2026 | Honore TageDirector | Sell | 30,000 | $8.03 | $241K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance